These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 16077990

  • 1. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck.
    Prévost A, Mérol JC, Aimé P, Moutel K, Roger-Liautaud F, Nasca S, Legros M, Coninx P.
    Oncol Rep; 2005 Sep; 14(3):771-6. PubMed ID: 16077990
    [Abstract] [Full Text] [Related]

  • 2. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 3. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M, Kanke M, Tomita T.
    Gan To Kagaku Ryoho; 1999 Oct 01; 26(11):1542-7. PubMed ID: 10553410
    [Abstract] [Full Text] [Related]

  • 4. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N, Kitahara S, Tamura E, Tanabe T, Nakanoboh M, Kawada M, Shirasaka T.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():592-9. PubMed ID: 10895216
    [Abstract] [Full Text] [Related]

  • 5. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 6. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M.
    Gan To Kagaku Ryoho; 1996 Nov 01; 23(13):1740-6. PubMed ID: 8937483
    [Abstract] [Full Text] [Related]

  • 7. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N, Ichikawa G, Shirasaka T, Inuyama Y, Kawaida M, Ohnuma T.
    Gan To Kagaku Ryoho; 1995 Aug 01; 22 Suppl 3():209-14. PubMed ID: 7661582
    [Abstract] [Full Text] [Related]

  • 8. Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.
    Le QT, Taira A, Budenz S, Jo Dorie M, Goffinet DR, Fee WE, Goode R, Bloch D, Koong A, Martin Brown J, Pinto HA.
    Cancer; 2006 May 01; 106(9):1940-9. PubMed ID: 16532436
    [Abstract] [Full Text] [Related]

  • 9. Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
    Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A.
    Int J Oncol; 2002 Feb 01; 20(2):419-27. PubMed ID: 11788911
    [Abstract] [Full Text] [Related]

  • 10. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
    Matzinger O, Roelofsen F, Mineur L, Koswig S, Van Der Steen-Banasik EM, Van Houtte P, Haustermans K, Radosevic-Jelic L, Mueller RP, Maingon P, Collette L, Bosset JF, EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups.
    Eur J Cancer; 2009 Nov 01; 45(16):2782-91. PubMed ID: 19643599
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 01; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 12. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33 Suppl 1():167-71. PubMed ID: 16897996
    [Abstract] [Full Text] [Related]

  • 13. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W, Kurihara M, Hasegawa K, Chonan A, Kubo Y, Maekawa R, Iwasaki R, Sasai T, Fukuyama Y, Ishikawa K, Miyoshi K, Yasutake K, Hayakawa M.
    Oncol Rep; 2004 Sep 01; 12(3):557-61. PubMed ID: 15289837
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 01; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 15. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M, Yanagisawa T, Kishimoto H, Yoshioka W, Teranobu O, Shigeta Y, Komori T, Shimada K, Ohnishi M, Tanaka Y, Kamiya Y, Akazawa N, Oko T, Takahashi N, Adachi R, Tanigaki S, Hirata Y, Yakushiji N, Kitamura R, Hashikawa N, Hyogo Oncology Group for Oromaxillary Tumors.
    Gan To Kagaku Ryoho; 2001 Jun 01; 28(6):789-95. PubMed ID: 11432346
    [Abstract] [Full Text] [Related]

  • 16. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P, Putnik K, Kreimeyer T, Sprague LD, Koelbl O, Schäfer C.
    BMC Cancer; 2006 Dec 07; 6():279. PubMed ID: 17150114
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
    Baghi M, Hambek M, May A, Radeloff A, Gstoettner W, Knecht R.
    Anticancer Res; 2006 Dec 07; 26(1B):559-63. PubMed ID: 16739320
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.
    De Andrés L, Brunet J, López-Pousa A, Burgués J, Vega M, Tabernero JM, Mesía R, López JJ.
    J Clin Oncol; 1995 Jun 07; 13(6):1493-500. PubMed ID: 7751897
    [Abstract] [Full Text] [Related]

  • 19. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
    Tohnai I, Kawabe Y, Nakashima T, Yamagiwa M, Suzuki T, Mizuno A, Mineda H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct 20; 25(10):2567-78. PubMed ID: 1702133
    [Abstract] [Full Text] [Related]

  • 20. A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer.
    Imada T, Sairenji M, Suda T, Yamamoto Y, Amano T, Motohashi H.
    Hepatogastroenterology; 1999 Oct 20; 46(25):594-600. PubMed ID: 10228867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.